Target intelligence / Profile preview

Venezuelan equine encephalitis virus antigen (VEEV antigen)

Target
VEEV antigen
Molecular classification
Other
01

Overview

"Venezuelan equine encephalitis virus antigen" is a non-specific collective term for viral proteins of VEEV, an Alphavirus (family Togaviridae) that causes outbreaks of encephalitis in horses and humans[4]. The virus is composed of a single-stranded RNA genome (~11.5 kb) encoding nonstructural replication proteins and structural proteins, including the **envelope glycoproteins E1 and E2** (mediating cell entry and key antibody targets), and the **capsid protein**. These viral proteins act as antigens, eliciting host immune responses during infection or after vaccination, and are the basis of serological diagnostics and immunization strategies[1][4][5][6][7]. Research and immunotherapeutic or vaccine development specifically target individual proteins (e.g., E2 glycoprotein), not the general antigen designation.

Other names
VEE antigenVEEV antigenVenezuelan equine encephalitis virus protein (non-specific)
02

Mechanism of action

Neutralization of viral attachment and entry (by antibodies, especially against E2 or E1 proteins) Inhibition of membrane fusion (block by antibodies against E1/E2)

03

Biological functions

Immune response inductionViral entryViral assembly and replication
04

Disease associations

Infection
05

Safety considerations

Use of live-attenuated vaccines (e.g., TC-83) can cause adverse reactions in some recipientsFormalin-inactivated vaccines carry residual infectivity risk if not completely inactivatedRisk of laboratory-acquired infection (VEEV is a BSL-3 pathogen and potential bioweapon)
06

Interacting drugs

monoclonal antibodies

1 more in the full profile.

07

Biomarkers

Serological detection of anti-VEEV IgM (acute infection)Neutralizing antibody titers against VEEV envelope proteins (for vaccine efficacy)

Beyond the preview

Go deeper on Venezuelan equine encephalitis virus antigen (VEEV antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venezuelan equine encephalitis virus antigen (VEEV antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call